Clinical Trials
11 trialsNCT00003008 2023-06-15
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00090987 2018-06-06
Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT00003657 2017-01-20
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00474994 2016-01-20
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02137564 2015-07-23
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Withdrawn
NCT00005042 2014-08-29
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT00003419 2013-09-20
Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00019123 2013-08-16
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00019240 2013-06-20
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
National Cancer Institute (NCI)
Phase 2 Completed
NCT00020449 2013-06-19
Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00064142 2013-06-05
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed